JOURNAL BROWSE
Search
Advanced SearchSearch Tips
Downregulation of Cyclin D1 by Sophorae Flos through Proteasomal Degradation in Human Colorectal Cancer Cells
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Korean Journal of Plant Resources
  • Volume 28, Issue 6,  2015, pp.727-733
  • Publisher : The Plant Resources Society of Korea
  • DOI : 10.7732/kjpr.2015.28.6.727
 Title & Authors
Downregulation of Cyclin D1 by Sophorae Flos through Proteasomal Degradation in Human Colorectal Cancer Cells
Lee, Jin Wook; Park, Gwang Hun; Eo, Hyun Ji; Jeong, Jin Boo;
  PDF(new window)
 Abstract
Although Sophorae Flos (SF) has been reported to exert an anti-cancer activity, molecular targets and mechanisms associated with anti-cancer activity of SF have been unclear. Because cyclin D1 has been regarded as an important regulator in the cell proliferation, we focused cyclin D1 and investigated the effect of SF on the cyclin D1 regulation in light of elucidating the molecular mechanism for SF’s anti-cancer activity. The treatment of SF decreased cellular accumulation of cyclin D1 protein. However, SF did not change the level of cyclin D1 mRNA. Inhibition of proteasomal degradation by MG132 attenuated SF-mediated cyclin D1 downregulation and the half-life of cyclin D1 was decreased in the cells treated with SF. In addition, a point mutation of threonine-286 to alanine attenuated SF-mediated cyclin D1 downregulation. Inhibition of ERK1/2 by a selective inhibitor, PD98059 suppressed cyclin D1 downregulation by SF. From these results, we suggest that SF-mediated cyclin D1 downregulation may result from proteasomal degradation through its threonine-286 phosphorylation via ERK1/2. SF-induced proteasomal degradation of cyclin D1 might inhibit proliferation in human colorectal cancer cells. The current study provides information on molecular events for an anti-cancer activity of SF
 Keywords
Sophorae Flos;Cyclin D1;Anti-cancer;Human colorectal cancer;
 Language
English
 Cited by
 References
1.
Abe, M., O. Suzuki, K. Tasaki, K. Tominaga and H. Wakasa. 1996. Analysis of lectin binding properties on human Burkitt’s lymphoma cell lines that show high spontaneous metastasis to distant organs in SCID mice: the binding sites for soybean agglutinin lectin masked by sialylation are closely associated with metastatic lymphoma cells. Pathol. Int. 46:977-983. crossref(new window)

2.
Alao, J.P. 2007. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol. Cancer 6:24.

3.
Bahnassy, A.A., A.R. Zekri, S. El-Houssini, A.M. El-Shehaby, M.R. Mahmoud, S. Abdallah and M. El-Serafi. 2004. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol. 23:22-24.

4.
Barnes, D.M. and C.E. Gillett. 1998. Cyclin D1 in breast cancer. Breast Cancer Res. Treat. 52:1-5. crossref(new window)

5.
Bartkova, J., J. Lukas, H. Muller, D. Lutzhoft, M. Strauss and J. Bartek. 1994. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer. 57:353-361. crossref(new window)

6.
Diehl, J.A., M. Cheng, M.F. Roussel and C.J. Sherr. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12:3499-3511. crossref(new window)

7.
Diehl, J.A., F. Zindy and C.J. Sherr. 1997. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:957-972. crossref(new window)

8.
Hall, M. and G. Peters. 1996. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68:67-108. crossref(new window)

9.
Jung, C.H., S. Zhou, G.X. Ding, J.H. Kim, M.H. Hong, Y.C. Shin, G.J. Kim and S.G. Ko. 2006. Antihyperglycemic activity of herb extracts on streptozotocin-induced diabetic rats. Biosci. Biotechnol. Biochem. 70:2556-2559. crossref(new window)

10.
Kang, S.C., C.M. Lee, H. Choi, J.H. Lee, J.S. Oh, J.H. Kwak and O.P. Zee. 2006. Evaluation of oriental medicinal herbs for estrogenic and antiproliferative activities. Phytother. Res. 20:1017-1019. crossref(new window)

11.
Kim, B.H., E.Y. Chung, B.K. Min, S.H. Lee, M.K. Kim, K.R. Min and Y. Kim Y. 2003a. Anti-inflammatory action of legume isoflavonoid sophoricoside through inhibition on cyclooxygenase-2 activity. Planta Med. 69:474-476. crossref(new window)

12.
Kim, B.H., E.Y. Chung, J.C. Ryu, S.H. Jung, K.R. Min and Y. Kim. 2003b. Anti-inflammatory mode of isoflavone glycoside sophoricoside by inhibition of interleukin-6 and cyclooxygenase-2 in inflammatory response. Arch. Pharm. Res. 26:306-311. crossref(new window)

13.
Kim, J.K. and J.A. Diehl. 2009. Nuclear cyclin D1: An oncogenic driver in human cancer. J. Cell. Physiol. 220:292-296. crossref(new window)

14.
Knudsen, K.E., J.A. Diehl, C.A. Haiman and E.S. Knudsen. 2006. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 25:1620-1628. crossref(new window)

15.
Kwak, Y.T., R. Li, C.R. Becerra, D. Tripathy, E.P. Frenkel and U.N. Verma. 2005. IkappaB kinase alpha regulates subcellular distribution and turnover of cyclin D1 by phosphorylation. J. Biol. Chem. 280:33945-33952. crossref(new window)

16.
Langenfeld, J., H. Kiyokawa, D. Sekula, J. Boyle and E. Dmitrovsky. 1997. Post-translational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism. Proc. Natl. Acad. Sci. USA. 94:12070-12074. crossref(new window)

17.
Lee, J.W., G.H. Park, H.J. Eo, H.M. Song, M.K. Kim, M.J. Kwon, J.S. Koo, J.R. Lee, M.H. Lee and J.B. Jeong. 2015. Anti-cancer activity of the flower bud of Sophora japonica L. through upregulating activating transcription factor 3 in human colorectal cancer cells. Korean J. Res. Plants 28(3): 297-304. crossref(new window)

18.
Lo, Y.H., R.D. Lin, Y.P. Lin, Y.L. Liu and M.H. Lee. 2009. Active constituents from Sophora japonica exhibiting cellular tyrosinase inhibition in human epidermal melanocytes. J. Ethnopharmacol. 124:625-629. crossref(new window)

19.
Okabe, H., S.H. Lee, J. Phuchareon, D.G. Albertson, F. McCormick and O. Tetsu. 2006. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PloS One 1:e128. crossref(new window)

20.
Shinozaki, H., S. Ozawa, N. Ando, H. Tsuruta, M. Terada, M. Ueda and M. Kitajima. 1996. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin. Cancer Res. 2:1155-1161.

21.
Tang, Y.P., Y.F. Li, J. Hu and F.C. Lou. 2002. Isolation and identification of antioxidants from Sophora japonica. J. Asian Nat. Prod. Res. 4:123-128. crossref(new window)

22.
Thoms, H.C., M.G. Dunlop and L.A. Stark. 2007. p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells. Cancer Res. 67:1660-1669. crossref(new window)

23.
Vermeulen, K., D.R. Van Bockstaele and Z.N. Berneman. 2003. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 36:131-149. crossref(new window)